Canadian Respiratory Journal / 2018 / Article / Tab 2

Research Article

The Serum Level of IL-1B Correlates with the Activity of Chronic Pulmonary Aspergillosis

Table 2

Multiple linear regression model for predicting serum IL-1B using age, gender, BMI, smoking status, TB, NTM infection, lung abscess, other acute respiratory infections, cancer, COPD, AIP, sarcoidosis, other interstitial diseases, diabetes mellitus, hypertension, cardiac disease, cerebrovascular disease, systemic CS or IS therapy, and pulmonary surgery history as covariates in all the subjects with chronic pulmonary aspergillosis.

Comorbid conditionsβ CoefficientStandard error value

TBNone (reference)
Treated0.0030.1060.978
Active/being treated0.4750.1380.001
NTM infection0.5380.1960.006
Lung abscess0.9750.3040.001
Other acute respiratory infection0.5470.1510.000
Cancer0.5420.1470.000
COPDNone (reference)
Stable0.1190.1020.247
Acute0.6120.1640.000
AIP0.8180.3050.008
Sarcoidosis0.4070.1850.028
Systemic CS or IS therapy−0.2970.1440.039

AIP: acute interstitial pneumonia; COPD: chronic obstructive pulmonary disease; CS: corticosteroid; ILD: interstitial lung disease; IS: immunosuppressive; NTM: nontuberculous mycobacterium.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.